PAPER Otoki Y, Kato S, Nakagawa K, Harvey DJ, Jin LW, Dugger BN, Taha AY
SEARCH RESULTS
408 RESULTS
PAPER Veronese M, Tuosto M, Marques TR, Howes O, Pascual B, Yu M, Masdeu JC, Turkheimer F, Bertoldo A, Zanotti-Fregonara P
Parametric Mapping for TSPO PET Imaging with Spectral Analysis Impulsive Response Function.
Mol Imaging Biol. 2021 Jan 21; PubMed: 33475944PAPER Moscoso A, Grothe MJ, Schöll M, Alzheimer’s Disease Neuroimaging Initiative
Reduced [18F]flortaucipir retention in white matter hyperintensities compared to normal-appearing white matter.
Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2283-2294. Epub 2021 Jan 21 PubMed: 33475761PAPER Zhou K, Yang F, Li Y, Chen Y, Zhang X, Zhang J, Wang J, Dai J, Cai L, Cui M
Synthesis and Evaluation of Fluorine-18 Labeled 2-Phenylquinoxaline Derivatives as Potential Tau Imaging Agents.
Mol Pharm. 2021 Mar 1;18(3):1176-1195. Epub 2021 Jan 21 PubMed: 33475377PAPER Wen W, Li P, Liu P, Xu S, Wang F, Huang JH
Post-Translational Modifications of BACE1 in Alzheimer's Disease.
Curr Neuropharmacol. 2021 Jan 21; PubMed: 33475074PAPER Ferrari C, Sorbi S
The complexity of Alzheimer's disease: an evolving puzzle.
Physiol Rev. 2021 Jul 1;101(3):1047-1081. Epub 2021 Jan 21 PubMed: 33475022PAPER Carosi JM, Denton D, Kumar S, Sargeant TJ
Retromer dysfunction at the nexus of tauopathies.
Cell Death Differ. 2021 Mar;28(3):884-899. Epub 2021 Jan 20 PubMed: 33473181PAPER Wagatsuma K, Miwa K, Sakata M, Ishibashi K, Ishii K
[Cross-validation of Quantitative Analytical Software Using 18F-florbetapir PET Imaging].
Nihon Hoshasen Gijutsu Gakkai Zasshi. 2021;77(1):32-40. PubMed: 33473077PAPER Kelly JW
Does protein aggregation drive postmitotic tissue degeneration?
Sci Transl Med. 2021 Jan 20;13(577) PubMed: 33472954PAPER Sanchez JS, Becker JA, Jacobs HI, Hanseeuw BJ, Jiang S, Schultz AP, Properzi MJ, Katz SR, Beiser A, Satizabal CL, O'Donnell A, DeCarli C, Killiany R, El Fakhri G, Normandin MD, Gómez-Isla T, Quiroz YT, Rentz DM, Sperling RA, Seshadri S, Augustinack J, Price JC, Johnson KA
The cortical origin and initial spread of medial temporal tauopathy in Alzheimer's disease assessed with positron emission tomography.
Sci Transl Med. 2021 Jan 20;13(577) PubMed: 33472953PAPER Kapadia M, Mian MF, Ma D, Hutton CP, Azam A, Narkaj K, Cao C, Brown B, Michalski B, Morgan D, Forsythe P, Zovkic IB, Fahnestock M, Sakic B
Differential effects of chronic immunosuppression on behavioral, epigenetic, and Alzheimer's disease-associated markers in 3xTg-AD mice.
Alzheimers Res Ther. 2021 Jan 20;13(1):30. PubMed: 33472690PAPER Zou XY, Xie RR, Li W, Su CL, Chen YS, Tang H
Novel sampangine derivatives as potent inhibitors of Cu2+-mediated amyloid-β protein aggregation, oxidative stress and inflammation.
Int J Biol Macromol. 2021 Mar 31;174:1-10. Epub 2021 Jan 18 PubMed: 33476619PAPER Yang YP, Huang YC, Chen CS, Yang YC, Wang JJ
Sensitivity and Specificity of the Saint Louis University Mental Status Examination to Detect Mild Cognitive Impairment and Dementia in Chinese Population.
Gerontology. 2021;67(2):152-159. Epub 2021 Jan 21 PubMed: 33477133Bruno Pietro Imbimbo on Myeloid Metabolic Crisis May Trigger Cognitive Decline in Aging Brain
COMMENT The recent work of Minhas and colleagues unveils the crucial role of myeloid prostaglandin EP2 signaling in the bioenergetic dysfunction processes that occur during aging. The authors demonstrated that in aged mice, both central and peripheral inhibition
Tommaso Croese, Michal Schwartz on Myeloid Metabolic Crisis May Trigger Cognitive Decline in Aging Brain
COMMENT For decades, cognitive deterioration occurring during aging was considered to be neuronal-centric, and thus was attributed solely to neuron exhaustion, dysfunction, or, in the extreme case, to neuronal loss. Over the last two decades, emerging studies des
Current Filters
- Date Range : Jan 2021 to Jan 2021 x